4//SEC Filing
Frapaise Francois-Xavier 4
Accession 0001142576-10-000040
CIK 0001142576other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 6:22 PM ET
Size
5.0 KB
Accession
0001142576-10-000040
Insider Transaction Report
Form 4
Frapaise Francois-Xavier
SVP, Chief Scientific Officer
Transactions
- Other
Common stock
2010-11-15$7.71/sh+1,305$10,061→ 4,211 total
Footnotes (1)
- [F1]Acquired under the Company's employee stock purchase plan on November 15, 2010.
Documents
Issuer
OPTIMER PHARMACEUTICALS INC
CIK 0001142576
Entity typeother
Related Parties
1- filerCIK 0001455044
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 6:22 PM ET
- Size
- 5.0 KB